A four-drug regimen for newly diagnosed high-risk multiple myeloma induced high rates of sustained minimal residual disease (MRD) negativity regardless of transplant status, a German resea… Read More
myelodysplastic syndrome bone marrow :: Article CreatorDiagnosis Of Myelodysplastic Syndrome (MDS) Myelodysplastic syndrome (MDS) can be difficult to diagnose. Man… Read More
Targeted protein degradation (TPD) is an emerging protein degradation technology in recent decades that utilizes the cell’s own protein clearance mechanisms, such as lysosomal deg… Read More
[Research Report] The T cell therapy market size was valued at US$ 2,754.0 million in 2022 and is expected to reach US$ 9,035.01 million by 2030. It is estimated to register a CAGR of 1… Read More
The B-Cell Lymphoma Pipeline Insight 2023 report by DelveInsight offers a thorough global overview of B-Cell Lymphoma treatments, including those already in the market, as well as those in… Read More
History of Thalidomide
During the 1950s-1960s, thalidomide was widely used as an antiemetic for pregnant women, leading to a tragic outcome with thousands of cases of malformed babie… Read More
Bengaluru, Aug 10 (Always First) Indian pharmaceuticals giant Biocon registered Rs 3,516 crore revenues for Quarter 1 of FY 2024.
An official statement issued by the company on Thursday sai… Read More
In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. With each passing… Read More
CHICAGO — A single infusion of the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel (cilta-cel; Carvykti) reduced the risk of disease progression or death c… Read More
Follow-up data from the EPCORE NHL-1 trial lend further support to the efficacy and safety of single-agent epcoritamab (Epkinly) in the treatment of relapsed/refractory diffuse large B-cel… Read More
A representational image of the human bloodstream. — Unsplash/File
New trial results presented Monday revealed treatment in which genetically modified human immune cells could decr… Read More
Oral presentations will highlight epcoritamab-bysp in combination with rituximab-lenalidomide (R2) in high-risk follicular lymphoma
Poster presentations will highlight epcoritamab in l… Read More
In a recent statement, the US-based chemical supplier Alfa Chemistry announced that it has added more than 200,000 chemicals to Spaya's chemical structure collection database.The partnership… Read More
DelveInsight Business Research LLP
DelveInsight’s “Erdheim-Chester Disease (ECD)- Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth… Read More
Geron Corporation GERN, a late-stage clinical biopharmaceutical company, today announced that data from the pivotal IMerge Phase 3 clinical trial evaluating the Company’s first-in… Read More
Targeted protein degradation (TPD) technology has been developed rapidly in recent years, especially proteolysis targeting chimeras (PROTACs). To date, a large number of degraders have been… Read More
Lakewood, Colorado, 2023-March-04 — /EPR Network/ —According to Regional Research Reports, “the Global Lenalidomide Market is projected to reach multi-millio… Read More
Initial Phase 1b study results show clinical activity with immune-based triplet therapy regimen NEW ORLEANS, Dec. 10, 2022 /PRNewswire/ — The Janssen Pharmaceutical Companies of J… Read More
DelveInsight’s, “Marginal Zone Lymphoma Pipeline Insight, 2022,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Marginal Zon… Read More
Lidmed 25 mg for Multiple Myeloma
Multiple myeloma is a kind of malignancy that develops in a certain type of white blood cells. These cells are known as plasma cells which produce antibodie… Read More
Many anti cancer drugs, antibiotics and vaccine will now become more affordable. After seven years, the government has released the National List of Essential Medicines (NLEM), 2022. The com… Read More
A complete of 34 medicines have been authorized within the NLEM 2022, which is an improve of NLEM 2015.
Ivermectin, a medicine used to deal with parasitic roundworm infections, which was… Read More
Anti-CD19 Antibody Pipeline
Approximately 15+ key companies are developing Anti-CD19 Antibody. The companies with their Anti-CD19 Antibody-drug candidates in the most advanced stag… Read More
CANOGEM – AntiCancer Medicine
GEMCITABINE INJECTION IP 200MG/1G
Combination therapy of Gemcitabine & Oxaliplatin has improved Overall Survival, Response Rate, and Time to… Read More
REVLIMID (lenalidomide)capsules https://gafacom.website/revlimid-lenalidomidecapsules/ MedicinesREVLIMID, a thalidomide analogue, is an immunomodulatory agent with antiangiogenic and antin… Read More
Boyd Huppert multiple myeloma or simply multiple myeloma is one of the rare kinds of cancer that develops in the plasma cells, a subtype of your WBCs. Plasma cells are present mainly in the… Read More
Cancer is a growing issue in today’s world, where cancer patients are increasing day by day. While the government has been actively involved in finding a cure for various types of canc… Read More
Hyderabad, Oct 19 (UNI) Dr. Reddy’s Laboratories Limited on Tuesday announced the final approval of its Abbreviated New Drug Application (ANDA) for Lenalidomide Capsules.Kolkata, Oct 1… Read More